portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Guangji Pharma sold its subsidiary Jifeng Industry Co for RMB 60mln to revive financial performance
 
CreateTime:2013-12-16 Editor:liaoyan
Text Size:       
 

Hubei Guangji Pharmaceutical Co.,Ltd. sold nearly half its share of Hubei Jifeng Industry Co for RMB 60 million. If the stock transfer procedure can be completed by the end of the year, Guangji Pharma could finish this year with over RMB 20 million revenue after 2 years deficit. 

As a public listed company, Guangji Pharma has experienced deficit for 2 years. After stripping of the assets and receiving various government subsidies, Guangji Pharma is highly possible to be earning this year.


Related Reports
China Blood Product Industry Report, 2020-2027
China Medical Robot Industry Report, 2020-2026
China In Vitro Diagnostic (IVD) Industry Report, 2019-2025
China Aged Care Industry Report, 2019-2025
China Dental Industry Report, 2019-2025
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1